EU regulator backs Gilead's twice-yearly injection for HIV prevention
(Reuters) -The European Union's drugs regulator has recommended approval of Gilead Sciences' lenacap...
25th July, 2025
(Reuters) -The European Union's drugs regulator has recommended approval of Gilead Sciences' lenacap...
25th July, 2025
By Max A. Cherney and Stephen Nellis SAN FRANCISCO (Reuters) -Intel warned investors on Thursday tha...
25th July, 2025
(Reuters) -French-Italian chipmaker STMicroelectronics said on Thursday it would acquire part of NXP...
25th July, 2025
By Heekyong Yang and Hyunjoo Jin SEOUL (Reuters) -South Korean battery firm LG Energy Solution warne...
25th July, 2025
(Reuters) -Starlink is experiencing a network outage, Elon Musk's SpaceX-owned satellite internet co...
24th July, 2025
By Sarah Mills LONDON (Reuters) -London's Kew Gardens will open a new garden focused on carbon that...
24th July, 2025
PARIS -Luxury bellwether LVMH reported a slightly worse than expected 4% decline in quarterly sales...
24th July, 2025
ABIDJAN (Reuters) -Small players in Ivory Coast's cocoa industry say they fear they will go out of b...
24th July, 2025
SARAJEVO (Reuters) -South African businessman Errol Musk, the father of billionaire Elon Musk, visit...
24th July, 2025
UNTERLUESS, Germany (Reuters) -The Franco-German MGCS main battle tank project, which has stalled fo...
24th July, 2025
(Reuters) -Banned for decades at men's games in England to curb hooliganism, alcohol will be allowed...
24th July, 2025
(Reuters) -Swiss drugmaker Novartis will pay up to $1 billion to U.S. biotech Matchpoint Therapeutic...
24th July, 2025